Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control Following Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial.

Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Lobo MD, Sharp ASP, Bloch MJ, Basile J, Wang Y, Saxena M, Lurz P, Rader F, Sayer J, Fisher NDL, Fouassier D, Barman NC, Reeve-Stoffer H, McClure C, Kirtane AJ; RADIANCE-HTN Investigators.

Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.040451. [Epub ahead of print]

PMID:
30880441
2.

Development of an entirely remote, non-physician led hypertension management program.

Fisher NDL, Fera LE, Dunning JR, Desai S, Matta L, Liquori V, Pagliaro J, Pabo E, Merriam M, MacRae CA, Scirica BM.

Clin Cardiol. 2019 Feb;42(2):285-291. doi: 10.1002/clc.23141. Epub 2019 Jan 17.

3.

Hypertension-A Public Health Challenge of Global Proportions.

Fisher NDL, Curfman G.

JAMA. 2018 Nov 6;320(17):1757-1759. doi: 10.1001/jama.2018.16760. No abstract available.

PMID:
30398584
4.

Arginine impairs endothelial and executive function in older subjects with cardiovascular risk.

Beckman JA, Hurwitz S, Fisher NDL.

J Am Soc Hypertens. 2018 Oct;12(10):723-731. doi: 10.1016/j.jash.2018.07.002. Epub 2018 Jul 10.

PMID:
30057253
5.

Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.

Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Davies J, Basile J, Kirtane AJ, Wang Y, Lobo MD, Saxena M, Feyz L, Rader F, Lurz P, Sayer J, Sapoval M, Levy T, Sanghvi K, Abraham J, Sharp ASP, Fisher NDL, Bloch MJ, Reeve-Stoffer H, Coleman L, Mullin C, Mauri L; RADIANCE-HTN Investigators.

Lancet. 2018 Jun 9;391(10137):2335-2345. doi: 10.1016/S0140-6736(18)31082-1. Epub 2018 May 23. Erratum in: Lancet. 2018 Sep 8;392(10150):820.

PMID:
29803590
6.

Scaling Marker Position Determines the Accuracy of Digital Templating for Total Hip Arthroplasty.

Ramme AJ, Fisher ND, Egol J, Chang G, Vigdorchik JM.

HSS J. 2018 Feb;14(1):55-59. doi: 10.1007/s11420-017-9578-0. Epub 2017 Sep 12.

7.

Fracture Severity Based on Classification Does Not Predict Outcome Following Proximal Humerus Fracture.

Fisher ND, Barger JM, Driesman AS, Belayneh R, Konda SR, Egol KA.

Orthopedics. 2017 Nov 1;40(6):368-374. doi: 10.3928/01477447-20170925-04. Epub 2017 Oct 3.

PMID:
28968473
8.

Effects of alcohol consumption on blood pressure in hypertensive women.

Fisher NDL, Orav EJ, Chang G.

Am J Drug Alcohol Abuse. 2018;44(2):200-205. doi: 10.1080/00952990.2017.1355921. Epub 2017 Aug 14.

9.

Effect of Vitamin D on Endothelial Function: A Randomized, Double-Blind, Placebo-Controlled Trial.

Borgi L, McMullan C, Wohlhueter A, Curhan GC, Fisher ND, Forman JP.

Am J Hypertens. 2017 Feb;30(2):124-129. doi: 10.1093/ajh/hpw135. Epub 2016 Nov 15. Erratum in: Am J Hypertens. 2017 Jul 1;30(7):731.

10.

Effect of Uric Acid-Lowering Agents on Endothelial Function: A Randomized, Double-Blind, Placebo-Controlled Trial.

Borgi L, McMullan C, Wohlhueter A, Curhan GC, Fisher ND, Forman JP.

Hypertension. 2017 Feb;69(2):243-248. doi: 10.1161/HYPERTENSIONAHA.116.08488. Epub 2016 Dec 27.

11.

Maximum renal responses to renin inhibition in healthy study participants: VTP-27999 versus aliskiren.

Barkoudah E, van Thiel BS, Fisher ND, Gregg RA, Danser AH, Moukarbel GV, Hollenberg NK.

J Hypertens. 2016 May;34(5):935-41. doi: 10.1097/HJH.0000000000000860.

PMID:
26882043
12.

Impaired cerebrovascular hemodynamics are associated with cerebral white matter damage.

Purkayastha S, Fadar O, Mehregan A, Salat DH, Moscufo N, Meier DS, Guttmann CR, Fisher ND, Lipsitz LA, Sorond FA.

J Cereb Blood Flow Metab. 2014 Feb;34(2):228-34. doi: 10.1038/jcbfm.2013.180. Epub 2013 Oct 16.

13.

Neurovascular coupling, cerebral white matter integrity, and response to cocoa in older people.

Sorond FA, Hurwitz S, Salat DH, Greve DN, Fisher ND.

Neurology. 2013 Sep 3;81(10):904-9. doi: 10.1212/WNL.0b013e3182a351aa. Epub 2013 Aug 7.

14.

Habitual flavonoid intake and endothelial function in healthy humans.

Fisher ND, Hurwitz S, Hollenberg NK.

J Am Coll Nutr. 2012 Aug;31(4):275-9.

15.

Renal responses to three types of renin-angiotensin system blockers in patients with diabetes mellitus on a high-salt diet: a need for higher doses in diabetic patients?

Hollenberg NK, Fisher ND, Nussberger J, Moukarbel GV, Barkoudah E, Danser AH.

J Hypertens. 2011 Dec;29(12):2454-61. doi: 10.1097/HJH.0b013e32834c627a.

16.

Renin inhibitors.

Fisher ND, Meagher EA.

J Clin Hypertens (Greenwich). 2011 Sep;13(9):662-6. doi: 10.1111/j.1751-7176.2011.00514.x. Epub 2011 Jul 27. Review.

17.

Brief intervention for women with risky drinking and medical diagnoses: a randomized controlled trial.

Chang G, Fisher ND, Hornstein MD, Jones JA, Hauke SH, Niamkey N, Briegleb C, Orav EJ.

J Subst Abuse Treat. 2011 Sep;41(2):105-14. doi: 10.1016/j.jsat.2011.02.011. Epub 2011 Apr 12.

18.

Identification of risk drinking women: T-ACE screening tool or the medical record.

Chang G, Fisher ND, Hornstein MD, Jones JA, Orav EJ.

J Womens Health (Larchmt). 2010 Oct;19(10):1933-9. doi: 10.1089/jwh.2009.1911.

19.

Brain blood flow and velocity: correlations between magnetic resonance imaging and transcranial Doppler sonography.

Sorond FA, Hollenberg NK, Panych LP, Fisher ND.

J Ultrasound Med. 2010 Jul;29(7):1017-22.

20.

Renal plasma flow: glomerular filtration rate relationships in man during direct renin inhibition with aliskiren.

Splenser AE, Fisher ND, Danser AH, Hollenberg NK.

J Am Soc Hypertens. 2009 Sep-Oct;3(5):315-20. doi: 10.1016/j.jash.2009.06.004. Epub 2009 Aug 19.

PMID:
20409974
21.

Flavanols, the Kuna, cocoa consumption, and nitric oxide.

Hollenberg NK, Fisher ND, McCullough ML.

J Am Soc Hypertens. 2009 Mar-Apr;3(2):105-12. doi: 10.1016/j.jash.2008.11.001. Epub 2009 Feb 20.

22.

Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans.

Forman JP, Williams JS, Fisher ND.

Hypertension. 2010 May;55(5):1283-8. doi: 10.1161/HYPERTENSIONAHA.109.148619. Epub 2010 Mar 29.

23.

Physical activity and albuminuria.

Robinson ES, Fisher ND, Forman JP, Curhan GC.

Am J Epidemiol. 2010 Mar 1;171(5):515-21. doi: 10.1093/aje/kwp442. Epub 2010 Feb 4.

24.

Post-menopausal hormone use and albuminuria.

Schopick EL, Fisher ND, Lin J, Forman JP, Curhan GC.

Nephrol Dial Transplant. 2009 Dec;24(12):3739-44. doi: 10.1093/ndt/gfp321. Epub 2009 Jul 2.

25.

Genetic polymorphisms and the risk of accelerated renal function decline in women.

Cooper Worobey C, Fisher ND, Cox D, Forman JP, Curhan GC.

PLoS One. 2009;4(3):e4787. doi: 10.1371/journal.pone.0004787. Epub 2009 Mar 10.

26.

Vitamin D-mediated hypercalcemia and Cushing syndrome as manifestations of malignant pleural mesothelioma.

Lee JM, Pou K, Sadow PM, Chen H, Hu B, Hewison M, Adams JS, Sugarbaker DJ, Fisher ND.

Endocr Pract. 2008 Nov;14(8):1011-6.

PMID:
19095601
27.

Aliskiren accumulates in Renin secretory granules and binds plasma prorenin.

Krop M, Garrelds IM, de Bruin RJ, van Gool JM, Fisher ND, Hollenberg NK, Jan Danser AH.

Hypertension. 2008 Dec;52(6):1076-83. doi: 10.1161/HYPERTENSIONAHA.108.123042. Epub 2008 Nov 3.

PMID:
18981317
28.

Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans.

Sorond FA, Lipsitz LA, Hollenberg NK, Fisher ND.

Neuropsychiatr Dis Treat. 2008 Apr;4(2):433-40.

29.

Higher levels of albuminuria within the normal range predict incident hypertension.

Forman JP, Fisher ND, Schopick EL, Curhan GC.

J Am Soc Nephrol. 2008 Oct;19(10):1983-8. doi: 10.1681/ASN.2008010038. Epub 2008 Jun 25.

30.

Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.

Fisher ND, Jan Danser AH, Nussberger J, Dole WP, Hollenberg NK.

Circulation. 2008 Jun 24;117(25):3199-205. doi: 10.1161/CIRCULATIONAHA.108.767202. Epub 2008 Jun 16.

PMID:
18559696
31.

Angiotensinogen genotype predicts abnormal renal hemodynamics in young hypertensive patients.

Patel TV, Williams GH, Fisher ND.

J Hypertens. 2008 Jul;26(7):1353-9. doi: 10.1097/HJH.0b013e3282ffb417.

PMID:
18551010
32.

Renin-angiotensin system polymorphisms and risk of hypertension: influence of environmental factors.

Forman JP, Fisher ND, Pollak MR, Cox DG, Tonna S, Curhan GC.

J Clin Hypertens (Greenwich). 2008 Jun;10(6):459-66.

33.

Is it the dark in dark chocolate?

Hollenberg NK, Fisher ND.

Circulation. 2007 Nov 20;116(21):2360-2. No abstract available.

PMID:
18025400
34.

Short- and long-term glycaemic control and the state of the renin system in type 1 diabetes mellitus.

Stevanovic RD, Fisher ND, Lansang CM, Freeman KD, Hollenberg NK.

J Renin Angiotensin Aldosterone Syst. 2007 Jun;8(2):85-92.

PMID:
17703435
35.

Gender and the renal nitric oxide synthase system in healthy humans.

Ahmed SB, Fisher ND, Hollenberg NK.

Clin J Am Soc Nephrol. 2007 Sep;2(5):926-31. Epub 2007 Aug 8.

36.

Racial differences in renal vascular response to angiotensin blockade with captopril or candesartan.

Forman JP, Price DA, Stevanovic R, Fisher ND.

J Hypertens. 2007 Apr;25(4):877-82.

PMID:
17351382
37.

Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes.

Stankovic AR, Fisher ND, Hollenberg NK.

J Am Soc Nephrol. 2006 Dec;17(12):3293-9. Epub 2006 Nov 8.

38.

Aging and vascular responses to flavanol-rich cocoa.

Fisher ND, Hollenberg NK.

J Hypertens. 2006 Aug;24(8):1575-80.

PMID:
16877960
39.

Cocoa flavanols and brain perfusion.

Fisher ND, Sorond FA, Hollenberg NK.

J Cardiovasc Pharmacol. 2006;47 Suppl 2:S210-4.

PMID:
16794460
40.

Renin release in response to Renin system blockade: activation of the Renin system in type 1 diabetes mellitus.

Stevanovic RD, Price DA, Lansang MC, Fisher ND, Laffel LM, Hollenberg NK.

J Renin Angiotensin Aldosterone Syst. 2005 Sep;6(2):78-83.

PMID:
16470486
41.

Body mass index and angiotensin-dependent control of the renal circulation in healthy humans.

Ahmed SB, Fisher ND, Stevanovic R, Hollenberg NK.

Hypertension. 2005 Dec;46(6):1316-20. Epub 2005 Nov 14.

PMID:
16286575
42.

Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy.

Ahmed SB, Hovind P, Parving HH, Rossing P, Price DA, Laffel LM, Lansang MC, Stevanovic R, Fisher ND, Hollenberg NK.

Diabetes Care. 2005 Aug;28(8):1988-94.

PMID:
16043743
43.

Flavanols for cardiovascular health: the science behind the sweetness.

Fisher ND, Hollenberg NK.

J Hypertens. 2005 Aug;23(8):1453-9. Review.

PMID:
16003167
44.

Genetics of human hypertension.

Agarwal A, Williams GH, Fisher ND.

Trends Endocrinol Metab. 2005 Apr;16(3):127-33. Review.

PMID:
15808811
45.

Renin inhibition: what are the therapeutic opportunities?

Fisher ND, Hollenberg NK.

J Am Soc Nephrol. 2005 Mar;16(3):592-9. Epub 2005 Feb 9. Review.

46.

Uric acid and the state of the intrarenal renin-angiotensin system in humans.

Perlstein TS, Gumieniak O, Hopkins PN, Murphey LJ, Brown NJ, Williams GH, Hollenberg NK, Fisher ND.

Kidney Int. 2004 Oct;66(4):1465-70.

47.

Plasma aldosterone concentration in the patient with diabetes mellitus.

Hollenberg NK, Stevanovic R, Agarwal A, Lansang MC, Price DA, Laffel LM, Williams GH, Fisher ND.

Kidney Int. 2004 Apr;65(4):1435-9.

48.

Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans.

Fisher ND, Hughes M, Gerhard-Herman M, Hollenberg NK.

J Hypertens. 2003 Dec;21(12):2281-6.

PMID:
14654748
49.

The renin-angiotensin system in blacks: active, passive, or what?

Price DA, Fisher ND.

Curr Hypertens Rep. 2003 Jun;5(3):225-30. Review.

PMID:
12724055
50.

Controlled analysis of blood pressure sensitivity to sodium intake: interactions with hypertension type.

Hurwitz S, Fisher ND, Ferri C, Hopkins PN, Williams GH, Hollenberg NK.

J Hypertens. 2003 May;21(5):951-9.

PMID:
12714870

Supplemental Content

Loading ...
Support Center